Find the Signal !

We Specialize in Bridging Preclinical Discovery With
Early Stage Clinical Development

What We Do:

  • Selection of preclinical models that reflect the current clinical landscape.
  • Determination of the mechanism of action & discovery of candidate biomarkers.
  • Identification of lead compounds with the highest probability of clinical success.
  • Differentiation from standard of care and competitors for optimal clinical positioning.
  • Precision Medicine Approach to leverage disease heterogeneity and microenvironment.
  • Design of clinical assays to confirm target engagement & mechanism of action in patients.
  • Confirmation of biomarkers for patient stratification and late-phase clinical trial design.

Indications We Specialize In:

▶ Oncology
  • Solid Tumors and Hematological Cancers
  • Selection of Indication & Relevant Preclinical Models
  • Target Engagement (Whole Blood & Paired Biopsies)
▶ Cardiometabolic Diseases
  • Differentiation from latest therapies (triple G agonists, SGLT2 inhibitors).
  • Contribution of microenvironment to disease pathology.
  • Clinical design and endpoints.
▶ Fibrosis
  • Molecular Hallmarks of lung, heart, kidney & liver inflammation & fibrosis.
  • Tailored ex-vivo assays.
  • Circulating biomarkers (preclinical & clinical).
Scroll to Top